当前位置:首页 - 行情中心 - 冀衡医药(002742) - 财务分析 - 现金流量表

冀衡医药

(002742)

  

流通市值:19.59亿  总市值:25.59亿
流通股本:5.24亿   总股本:6.84亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金77,783,791.6842,699,318.2738,323,973.44578,749,349.49
  收到的税费返还--7,196,542.163,846,849.09
  收到其他与经营活动有关的现金6,908,840.69710,299.8327,342,414.4854,974,559.6
  经营活动现金流入小计84,692,632.3743,409,618.03772,862,930.08637,570,758.18
  购买商品、接受劳务支付的现金45,673,746.8739,177,273.4406,914,893.16306,067,249.82
  支付给职工以及为职工支付的现金51,338,575.5830,186,799.25174,480,185.57138,789,093.16
  支付的各项税费32,989,362.1222,265,370.63103,465,87977,078,971.25
  支付其他与经营活动有关的现金21,616,437.6914,392,804.35113,874,444.24104,031,200.41
  经营活动现金流出小计151,618,122.26106,022,247.63798,735,401.97625,966,514.64
  经营活动产生的现金流量净额-66,925,489.89-62,612,629.6-25,872,471.8911,604,243.54
二、投资活动产生的现金流量:
  收回投资收到的现金--3,000,000-
  取得投资收益收到的现金--2,142.65-
  处置固定资产、无形资产和其他长期资产收回的现金净额41,00041,0001,360,900.99707,090.5
  投资活动现金流入小计41,00041,0004,363,043.64707,090.5
  购建固定资产、无形资产和其他长期资产支付的现金1,656,899.241,040,249.249,418,210.086,701,886.26
  投资支付的现金--3,000,000-
  支付其他与投资活动有关的现金--26,938,710.31-
  投资活动现金流出小计1,656,899.241,040,249.2439,356,920.396,701,886.26
  投资活动产生的现金流量净额-1,615,899.24-999,249.24-34,993,876.75-5,994,795.76
三、筹资活动产生的现金流量:
  吸收投资收到的现金--254,200,000-
  取得借款收到的现金-50,000,000-31,428,000
  收到其他与筹资活动有关的现金50,000,000-46,936,027.7613,371,672.06
  筹资活动现金流入小计50,000,00050,000,000301,136,027.7644,799,672.06
  偿还债务支付的现金49,699,979.1749,600,00090,917,864.0622,192,784
  分配股利、利润或偿付利息支付的现金1,053,108.26733,663.8263,878,706.6341,953,045.42
  其中:子公司支付给少数股东的股利、利润--46,800,000-
  支付其他与筹资活动有关的现金782,719.12-31,543,308.5-
  筹资活动现金流出小计51,535,806.5550,333,663.82186,339,879.1964,145,829.42
  筹资活动产生的现金流量净额-1,535,806.55-333,663.82114,796,148.57-19,346,157.36
四、汇率变动对现金及现金等价物的影响-0-4,758,186-3,965,840.46
五、现金及现金等价物净增加额-70,077,195.68-63,945,542.6649,171,613.93-17,702,550.04
  加:期初现金及现金等价物余额104,663,764.52114,492,900.7555,492,150.5955,492,150.59
  期末现金及现金等价物余额34,586,568.8450,547,358.09104,663,764.5237,789,600.55
补充资料:
  净利润-20,723,540.22--458,788,954.47-
  资产减值准备--148,934,358.09-
  固定资产和投资性房地产折旧25,802,301.48-85,535,856.43-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧25,802,301.48-85,535,856.43-
  无形资产摊销1,591,010.37-7,377,955.93-
  长期待摊费用摊销1,840,195.04-6,875,642.26-
  处置固定资产、无形资产和其他长期资产的损失29,172.14-137,096.25-
  固定资产报废损失-135,922.79-11,460,256.66-
  财务费用8,757,997.81-206,199,821.87-
  投资损失-1,266,626.06-48,615,131.72-
  递延所得税2,225,205.64-7,846,165.77-
  其中:递延所得税资产减少2,225,205.64-7,846,165.77-
  存货的减少-16,816,163.33-74,906,580.94-
  经营性应收项目的减少-31,001,709.36-885,306,407.53-
  经营性应付项目的增加-37,227,410.61--1,050,278,790.87-
  现金的期末余额34,586,568.84-104,663,764.52-
  减:现金的期初余额104,663,764.52-55,492,150.59-
  现金及现金等价物的净增加额-70,077,195.68-49,171,613.93-
公告日期2026-08-152026-04-252026-03-312025-10-29
审计意见(境内)标准无保留意见
TOP↑